169 web-programmer-developer Postdoctoral research jobs at University of Oxford in United Kingdom
Sort by
Refine Your Search
-
their target antigens and become activated in serious human diseases, including autoimmune disorders, infectious diseases, and cancers. We study how adaptive T cell immunity is developed and/or becomes impaired
-
to a large-scale, interdisciplinary research programme. We are looking for someone with proven expertise in a fast-paced environment, who is committed to delivering high-quality research support and
-
-on leadership. You will also play a key role in shaping the future scientific direction of the group and supporting future grant development. About the Radcliffe Department of Medicine The Radcliffe Department
-
of comparative genomics and molecular evolution analyses to identify these targets. The project will make use of software developed in the Kelly group as well as other widely used software for biological sequence
-
spatial transcriptomics (Sanger/Copenhagen). Subsequent validation and exploration of targets will be performed using organoid biology (Oxford). You will work primarily within the Tumour Evolution and
-
a Postdoctoral Research Scientist, you will primarily be responsible for the development, design, and execution of experiments in the project, focusing on mapping the molecular characteristics
-
developing a novel platform to uncover the hidden dynamics of proteins in health and disease. Your Role As a postdoc on this project, you’ll be part of a dynamic team working at the intersection
-
developing a novel platform to uncover the hidden dynamics of proteins in health and disease. Your Role As a postdoc on this project, you will be part of a dynamic team working at the intersection of protein
-
aims to push the limits of label-free mass measurement of biomolecules in solution by integrating advanced optical techniques with state-of-the-art data analysis. Building on recent developments in mass
-
for Human Genetics in Oxford. The Tzima research group investigates the role of mechanotransduction in cardiovascular disease and the laboratory is at the cutting edge of developments in in vitro and in vivo